Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:1-2
Published online before print December 20, 2004, doi: 10.1161/01.HYP.0000152699.98982.66
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/1/1    most recent
01.HYP.0000152699.98982.66v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whelton, P. K.
Right arrow Articles by Moore, M. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Whelton, P. K.
Right arrow Articles by Moore, M. A.
Related Collections
Right arrow Clinical Studies

(Hypertension. 2005;45:1.)
© 2005 American Heart Association, Inc.


In Memoriam

W. Gordon Walker, MD, FACP

Paul K. Whelton; Michael A. Moore

Tulane University of Louisiana, New Orleans, Lousiaiana
Wake Forest University School of Medicine, Winston Salem, North Carolina, Danville, Virginia


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Dr W. Gordon Walker, a physician, scientist, clinical researcher, public health policy leader, and medical educator died in Baltimore, Maryland, on October 5, 2004, from pulmonary fibrosis. During his 53-year career, Gordon contributed to the world of medicine a better understanding of potassium physiology and the renin-angiotensin-aldosterone system, public policy to make renal replacement therapy available on a universal scale in the United States, and the relationship of hypertension and nutrition to progressive renal failure. He trained numerous physicians to whom he imparted Osler standards of excellence in clinical and academic medicine.

Born and raised in Lena, Louisiana, he was the grandson of a country doctor who practiced in Rapides Parish, Louisiana. His college education was received at Louisiana State University. On returning from the Navy at the end of World War II, he married his sweetheart of many years, Betty Couch of New Orleans, and entered the Tulane University School of Medicine under the GI Bill. With Betty supporting them, he focused on medical school, finishing at the top of his class as a member of Alpha Omega Alpha and being selected as an Osler medical intern at the Johns Hopkins Hospital. Gordon and Betty’s first child, Gordon, Jr. (Rusty), was born during the last year of medical school. Down


Figure Removed (Available Only in the Full Text)
View larger version (124K):
[in this window]
[in a new window]
 

As an Osler intern, Gordon adopted the principles and Hopkins work ethic of Sir William Osler. Dr Osler defined the concept of an academic physician and the role model of a physician constantly striving to understand the cause and treatment . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
X. C. Li, U. Hopfer, and J. L. Zhuo
AT1 receptor-mediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1342 - F1352.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Verdecchia, F. Angeli, C. Cavallini, R. Gattobigio, G. Gentile, J. A. Staessen, and G. Reboldi
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
Eur. Heart J., March 2, 2009; 30(6): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. A. S. Santos, A. J. Ferreira, and A. C. Simoes e Silva
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
Exp Physiol, May 1, 2008; 93(5): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Pons, V. Griol-Charhbili, C. Heymes, P. Fornes, D. Heudes, A. Hagege, X. Loyer, P. Meneton, J.-F. Giudicelli, J.-L. Samuel, et al.
Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice
Eur J Heart Fail, April 1, 2008; 10(4): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. A. Peralta, M. G. Shlipak, C. Wassel-Fyr, H. Bosworth, B. Hoffman, S. Martins, E. Oddone, and M. K. Goldstein
Association of Antihypertensive Therapy and Diastolic Hypotension in Chronic Kidney Disease
Hypertension, September 1, 2007; 50(3): 474 - 480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. C. Li and J. L. Zhuo
Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C367 - C378.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. B. Eap, M. Bochud, R. C. Elston, P. Bovet, M. P. Maillard, J. Nussberger, L. Schild, C. Shamlaye, and M. Burnier
CYP3A5 and ABCB1 Genes Influence Blood Pressure and Response to Treatment, and Their Effect Is Modified by Salt
Hypertension, May 1, 2007; 49(5): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. K. Koh, M. J. Quon, S. H. Han, W.-J. Chung, J. Y. Ahn, J.-a Kim, Y. Lee, and E. K. Shin
Additive Beneficial Effects of Fenofibrate Combined With Candesartan in the Treatment of Hypertriglyceridemic Hypertensive Patients
Diabetes Care, February 1, 2006; 29(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Sharma, E. T. McCarthy, R. Sharma, B. L. Fish, V. J. Savin, E. P. Cohen, and J. E. Moulder
Arachidonic Acid Metabolites Mediate the Radiation-Induced Increase in Glomerular Albumin Permeability
Experimental Biology and Medicine, January 1, 2006; 231(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. Koh, S. H. Han, and M. J. Quon
Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1978 - 1985.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Okumura, M. Iwai, A. Ide, M. Mogi, M. Ito, and M. Horiuchi
Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT2 Receptor Expression
Hypertension, September 1, 2005; 46(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Djousse, D. K. Arnett, J. J. Carr, J. H. Eckfeldt, P. N. Hopkins, M. A. Province, and R. C. Ellison
Dietary Linolenic Acid Is Inversely Associated With Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study
Circulation, June 7, 2005; 111(22): 2921 - 2926.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Sartori, A. C. Pessina, A. Semplicini, C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni
Orthostatic Hypotension and Supine Hypertension in Primary Autonomic Failure
Hypertension, June 1, 2005; 45(6): e18 - e19.
[Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey
Cardiovascular and Renal Regulation by the Angiotensin Type 2 Receptor: The AT2 Receptor Comes of Age
Hypertension, May 1, 2005; 45(5): 840 - 844.
[Full Text] [PDF]